Why actively promote vaccination in patients with cirrhosis?

Journal of Clinical Virology

Volumn 46, Issue 3, 2009, Pages 206-209

  Loulergue, Pierre ^a,b,c   Pol, Stanislas ^a,c   Mallet, Vincent ^a,c   Sogni, Philippe ^a,c   Launay, Odile ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c Institut Cochin   (France)

Author keywords

Cirrhosis; Hepatitis A; Hepatitis B; Influenza; Pneumococcal; Vaccine

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY TITER; HEALTH PROMOTION; HEPATITIS A; HEPATITIS B; IMMUNE DEFICIENCY; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; LIVER CIRRHOSIS; MORBIDITY; MORTALITY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; VACCINATION;

HEPATITIS A; HEPATITIS B; HUMANS; INFLUENZA, HUMAN; LIVER CIRRHOSIS; VACCINATION; VIRAL VACCINES; VIRUS DISEASES;

EID: 72049103404     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.05.006     Document Type: Review

References (39)

1. Bouza E., Pintado V., Rivera S., Blázquez R., Muñoz P., Cercenado E., et al. Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect 11 11 (2005) 919-924
2. Mendez-Sanchez N., Villa A.R., Zamora-Valdes D., Morales-Espinosa D., and Uribe M. Worldwide mortality from cirrhosis. Ann Hepatol 6 July-September (3) (2007) 194-195
3. Haute Autorité de Santé. Surveillance des malades atteints de cirrhose non compliquée et prévention primaire des complications; 2007.
4. O'Keefe S.J., El-Zayadi A.R., Carraher T.E., Davis M., and Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 2 September (8195 Pt 1) (1980) 615-617
5. Yoneyama K., Miyagishi K., Kiuchi Y., Shibata M., and Mitamura K. Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma. J Gastroenterol 37 12 (2002) 1028-1034
6. UK Department of Health. Immunization against infectious diseases; 2006.
7. Fiore A.E., Wasley A., and Bell B.P. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recom Rep 55 May (RR-7) (2006) 1-23
8. Loulergue P, Launay O. Vaccinations chez les patients ayant une cirrhose. Presse Med 2009 Jan 28. [Epub ahead of print].
9. Calendrier vaccinal 2008. Bulletin Epidemiologique Hebdomadaire. 2008; 16-7.
10. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 338 January (5) (1998) 286-290
11. Rezende G., Roque-Afonso A., Samuel D., Gigou M., Nicand E., Ferre V., et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 38 3 (2003) 613-618
12. Lefilliatre P., and Villeneuve J.P. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health 91 May-June (3) (2000) 168-170
13. Feray C., Gigou M., Samuel D., Reyes G., Bernuau J., Reynes M., et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 104 February (2) (1993) 549-555
14. Krogsgaard K., Wantzin P., Mathiesen L., and Ring-Larsen H. Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acute Programme. Scand J Gastroenterol 26 March (3) (1991) 275-280
15. Liaw Y.F., Yeh C.T., and Tsai S.L. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 95 October (10) (2000) 2978-2980
16. Guidotti L., and Chisari F. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1 (2006) 23-61
17. Zarski J.P., Bohn B., Bastie A., Pawlotsky J.M., Baud M., Bost-Bezeaux F., et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 28 January (1) (1998) 27-33
18. Weltman M.D., Brotodihardjo A., Crewe E.B., Farrell G.C., Bilous M., Grierson J.M., et al. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 2 1 (1995) 39-45
19. Mohamed Ael S., al Karawi M.A., and Mesa G.A. Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients. Hepatogastroenterology 44 September-October (17) (1997) 1404-1406
20. Fattovich G., Bortolotti F., and Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48 (2008) 335-352
21. Coffin C.S., and Terrault N.A. Management of hepatitis B in liver transplant recipients. J Viral Hepat 14 November (Suppl. 1) (2007) 37-44
22. Joussemet M., Depaquit J., Nicand E., Mac Nab C., Meynard J.B., Teyssou R., et al. Fall in the seroprevalence of hepatitis A in French youth. Gastroenterol Clin Biol 23 April (4) (1999) 447-455
23. Bronowicki J.P., Weber-Larivaille F., Gut J.P., Doffoel M., and Vetter D. Comparison of immunogenicity of vaccination and serovaccination against hepatitis B virus in patients with alcoholic cirrhosis. Gastroenterol Clin Biol 21 11 (1997) 848-853
24. Marusawa H., Osaki Y., Kimura T., Ito K., Yamashita Y., Eguchi T., et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 45 2 (1999) 284-288
25. Arguedas M.R., McGuire B.M., and Fallon M.B. Implementation of vaccination in patients with cirrhosis. Dig Dis Sci 47 February (2) (2002) 384-387
26. Denis F., Delpeyroux C., Debrock C., Rogez S., and Alain S. Seroprevalence of hepatitis A in hospitalized patients in Limoges University Hospital. Gastroenterol Clin Biol 27 August-September (8-9) (2003) 727-731
27. Jacobs R.J., Meyerhoff A.S., and Saab S. Immunization needs of chronic liver disease patients seen in primary care versus specialist settings. Dig Dis Sci 50 August (8) (2005) 1525-1531
28. Mast E.E., Weinbaum C.M., Fiore A.E., Alter M.J., Bell B.P., Finelli L., et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II. Immunization of adults. MMWR Recom Rep 55 December (RR-16) (2006) 1-33 [quiz CE1-4]
29. Rey D., Krantz V., Partisani M., Schmitt M.P., Meyer P., Libbrecht E., et al. Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine 18 January (13) (2000) 1161-1165
30. Duchini A., Viernes M.E., Nyberg L.M., Hendry R.M., and Pockros P.J. Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch Intern Med 160 January (1) (2000) 113-115
31. Kyaw M.H., Rose Jr. C.E., Fry A.M., Singleton J.A., Moore Z., Zell E.R., et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 192 August (3) (2005) 377-386
32. Cheong H.J., Song J.Y., Park J.W., Yeon J.E., Byun K.S., Lee C.H., et al. Humoral and cellular immune responses to influenza vaccine in patients with advanced cirrhosis. Vaccine 24 March (13) (2006) 2417-2422
33. Song J.Y., Cheong H.J., Ha S.H., Hwang I.S., Kee S.Y., Jeong H.W., et al. Clinical impact of influenza immunization in patients with liver cirrhosis. J Clin Virol 39 July (3) (2007) 159-163
34. Ramos Rincon J.M., Cuenca Estrella M., and Fernandez Guerrero M.L. Retrospective and comparative study of pneumococcal bacteremia in patients with chronic hepatopathy. Ann Intern Med 13 July (7) (1996) 313-316
35. Gransden W.R., Eykyn S.J., and Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. Br Med J (Clin Res Ed) 290 February (6467) (1985) 505-508
36. McCashland T.M., Preheim L.C., and Gentry M.J. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 181 2 (2000) 757-760
37. Conseil Supérieur d'Hygiène Belge. http://www.iph.fgov.be/flu/FR/CSH_Pneumo.pdf.
38. Shim M., Khaykis I., Park J., and Bini E.J. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology 42 September (3) (2005) 688-695
39. Belarbi L., Loulergue P., Calmus Y., Conti F., Grabar S., Rosenberg A.R., et al. Séroprévalence des virus des hépatites A, B et C et immunogénicité de la vaccination contre les hépatites A et B chez les patients candidats à une transplantation hépatique. 9 es Journées Nationales d'Infectiologie. Marseille; June 4-6 (2008) [Abstract A04]